Dr. Jorge Marrero is a Professor of Medicine at UT Southwestern Medical Center, and Medical Director of Liver Transplantation. He is world renowned for his work in hepatocellular carcinoma (HCC) and liver transplantation. His research focus covers early diagnosis, staging and novel therapies in the field of HCC. In terms of early diagnosis, he has performed several studies that validated novel biomarkers. He currently is the principal investigator of an NCI-funded to prospectively validate these serum markers in those with cirrhosis. He has worked on diagnosis of HCC, specifically with imaging criteria for this tumor. He has published several manuscripts on treatment, specifically on liver transplantation for early stage HCC and on novel therapies for advanced HCC. He is a founding member of the International Liver Cancer Association, a member of The American Association for the Study of Liver Disease and the American Gastroenterological Association. Dr. Marrero has lectured globally and has written and reviewed numerous research articles and book chapters on hepatocellular carcinoma.